Skip to main content
HairCited

Ophiasis alopecia areata treated with microneedling.

Usman Asad, Daniel Wallis, Michelle Tarbox
Case Report Proceedings (Baylor University. Medical Center) 2020 8 citations
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D32675968'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Study Type
case report
Sample Size
1
Duration
24 weeks
Intervention
Ophiasis alopecia areata treated with microneedling. 4 microneedling sessions with triamcinolone over 6 months; clobetasol 0.05% solution
Comparator
Placebo
Effect Direction
Positive
Risk of Bias
High

Abstract

Alopecia areata (AA) is a T cell-mediated autoimmune disease resulting in the destruction of hair follicles. Ophiasis refers to a subtype of AA that presents as a symmetric, band-like hair loss pattern of the occipital, temporal, and parietal regions of the scalp. We present a case of a 58-year-old white man with AA, ophiasis pattern, who was treated with clobetasol 0.05% solution and four treatments of microneedling with triamcinolone over 6 months. He underwent gradual improvement, most notably on his left occipital scalp where his hair loss was most prominent, with near complete hair regrowth on his left occipital scalp. Microneedling with triamcinolone can be considered as a promising treatment in cases of ophiasis AA.

Used In Evidence Reviews

Similar Papers